XML 37 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Oct. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Stock Options Activity The following table summarizes the activity related to the Company's stock options:
Outstanding Stock OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Life (in years)Aggregate Intrinsic Value
(in thousands)
Balance, January 31, 2021
8,871,890 $7.64 4.94$81,906 
Granted— $— 
Exercised(1,828,211)$9.32 
Forfeited or canceled(12,413)$8.98 
Balance, October 31, 2021
7,031,266 $7.20 4.42$38,099 
Vested and expected to vest6,975,464 $7.16 4.41$38,069 
Exercisable at October 31, 2021
6,752,516 $7.00 4.35$37,913 
Schedule of Nonvested RSU Activity The following table summarizes the activity related to the Company's restricted stock and restricted stock units:
OutstandingWeighted-Average Grant Date Fair Value
Balance as of January 31, 2021
9,545,352 $16.71 
Granted 6,980,125 $13.22 
Vested and converted to shares(3,335,112)$15.84 
Forfeited or canceled(2,277,690)$16.37 
Balance as of October 31, 2021
10,912,675 $14.81 
Schedule of Employee Stock Purchase Plan Valuation Assumptions
The Black-Scholes option pricing model assumptions used to calculate the fair value of shares, estimated at commencement, to be purchased during an ESPP offering period were as follows:
Three months ended October 31,Nine months ended October 31,
2021202020212020
Expected life (years)0.500.500.500.50
Expected volatility45.54%65.48%
45.54% - 59.24%
51.44% - 65.48%
Dividend yield
Risk-free rate0.05%0.12%
0.05% - 0.06%
0.12% - 0.29%
Schedule of Share-Based Compensation Expense The Company's stock-based compensation expense for the periods presented was as follows:
Three months ended October 31,Nine months ended October 31,
(in thousands)2021202020212020
Cost of revenue$1,840 $1,513 $5,597 $4,053 
Sales and marketing6,757 9,410 19,635 25,151 
Research and development5,469 4,228 15,285 12,104 
General and administrative5,389 4,136 13,938 12,581 
Total stock-based compensation expense$19,455 $19,287 $54,455 $53,889